HRP20080173T3 - IMIDAZOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF mGluR5 RECEPTOR MEDIATED DISORDERS - Google Patents
IMIDAZOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF mGluR5 RECEPTOR MEDIATED DISORDERSInfo
- Publication number
- HRP20080173T3 HRP20080173T3 HR20080173T HRP20080173T HRP20080173T3 HR P20080173 T3 HRP20080173 T3 HR P20080173T3 HR 20080173 T HR20080173 T HR 20080173T HR P20080173 T HRP20080173 T HR P20080173T HR P20080173 T3 HRP20080173 T3 HR P20080173T3
- Authority
- HR
- Croatia
- Prior art keywords
- alkyl
- treatment
- imidazole derivatives
- receptor mediated
- mediated disorders
- Prior art date
Links
- RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical class C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 title 1
- 102000012777 Metabotropic Glutamate 5 Receptor Human genes 0.000 title 1
- 108010065028 Metabotropic Glutamate 5 Receptor Proteins 0.000 title 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 title 1
- 230000001404 mediated effect Effects 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 4
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 1
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03014512 | 2003-07-03 | ||
PCT/EP2004/007177 WO2005003117A1 (en) | 2003-07-03 | 2004-07-01 | Imidazole derivatives iii |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20080173T3 true HRP20080173T3 (en) | 2008-06-30 |
Family
ID=33560749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20080173T HRP20080173T3 (en) | 2003-07-03 | 2008-04-15 | IMIDAZOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF mGluR5 RECEPTOR MEDIATED DISORDERS |
Country Status (27)
Country | Link |
---|---|
US (1) | US7091222B2 (pt) |
EP (1) | EP1644351B1 (pt) |
JP (1) | JP4571631B2 (pt) |
KR (1) | KR100719653B1 (pt) |
CN (1) | CN100562520C (pt) |
AR (1) | AR044973A1 (pt) |
AT (1) | ATE388145T1 (pt) |
AU (1) | AU2004253657B2 (pt) |
BR (1) | BRPI0412158A (pt) |
CA (1) | CA2531210C (pt) |
CO (1) | CO5660258A2 (pt) |
DE (1) | DE602004012268T2 (pt) |
DK (1) | DK1644351T3 (pt) |
ES (1) | ES2300789T3 (pt) |
HR (1) | HRP20080173T3 (pt) |
IL (1) | IL172821A (pt) |
MX (1) | MXPA06000193A (pt) |
MY (1) | MY142085A (pt) |
NO (1) | NO20060112L (pt) |
NZ (1) | NZ544454A (pt) |
PL (1) | PL1644351T3 (pt) |
PT (1) | PT1644351E (pt) |
RU (1) | RU2360911C2 (pt) |
SI (1) | SI1644351T1 (pt) |
TW (1) | TWI252849B (pt) |
WO (1) | WO2005003117A1 (pt) |
ZA (1) | ZA200600026B (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA80888C2 (en) * | 2003-06-05 | 2007-11-12 | Hoffmann La Roche | Imidazole derivatives as glutmate receptor antagonists |
US7452909B2 (en) * | 2003-09-04 | 2008-11-18 | Hoffman-La Roche Inc. | Imidazole derivatives |
DE602005007350D1 (de) * | 2004-06-01 | 2008-07-17 | Hoffmann La Roche | Pyridin-4-yl-ethynylimidazole und -pyrazole als antagonisten des mglu5-rezeptors |
SI1756086T1 (sl) * | 2004-06-01 | 2008-08-31 | Hoffmann La Roche | Piridin-4-il-etinil-imidazoli in pirazoli kot antagonisti receptorja mglu5 |
US20060173048A1 (en) * | 2005-02-03 | 2006-08-03 | Mcarthur Silvia G | Imidazole derivatives |
DE102005062987A1 (de) * | 2005-12-28 | 2007-07-05 | Grünenthal GmbH | Substituierte Propiolsäureamide und ihre Verwendung zur Herstellung von Arzneimitteln |
AU2007336369B2 (en) * | 2006-12-21 | 2013-01-17 | F. Hoffmann-La Roche Ag | Polymorphs of a mGluR5 receptor antagonist |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US304910A (en) * | 1884-09-09 | Robeet h | ||
US4882343A (en) * | 1987-08-28 | 1989-11-21 | G. D. Searle & Co. | Biarylalkylimidazole derivatives as anti-depressants |
TW544448B (en) * | 1997-07-11 | 2003-08-01 | Novartis Ag | Pyridine derivatives |
US7531529B2 (en) * | 2003-06-05 | 2009-05-12 | Roche Palo Alto Llc | Imidazole derivatives |
-
2004
- 2004-06-23 US US10/874,948 patent/US7091222B2/en not_active Expired - Fee Related
- 2004-07-01 RU RU2006103009/04A patent/RU2360911C2/ru not_active IP Right Cessation
- 2004-07-01 MX MXPA06000193A patent/MXPA06000193A/es active IP Right Grant
- 2004-07-01 AU AU2004253657A patent/AU2004253657B2/en not_active Ceased
- 2004-07-01 TW TW093119915A patent/TWI252849B/zh not_active IP Right Cessation
- 2004-07-01 PL PL04740542T patent/PL1644351T3/pl unknown
- 2004-07-01 CA CA2531210A patent/CA2531210C/en not_active Expired - Fee Related
- 2004-07-01 SI SI200430679T patent/SI1644351T1/sl unknown
- 2004-07-01 KR KR1020067000075A patent/KR100719653B1/ko not_active IP Right Cessation
- 2004-07-01 EP EP04740542A patent/EP1644351B1/en not_active Expired - Lifetime
- 2004-07-01 AT AT04740542T patent/ATE388145T1/de active
- 2004-07-01 PT PT04740542T patent/PT1644351E/pt unknown
- 2004-07-01 CN CNB2004800200680A patent/CN100562520C/zh not_active Expired - Fee Related
- 2004-07-01 ES ES04740542T patent/ES2300789T3/es not_active Expired - Lifetime
- 2004-07-01 WO PCT/EP2004/007177 patent/WO2005003117A1/en active IP Right Grant
- 2004-07-01 BR BRPI0412158-9A patent/BRPI0412158A/pt not_active IP Right Cessation
- 2004-07-01 AR ARP040102312A patent/AR044973A1/es unknown
- 2004-07-01 JP JP2006518089A patent/JP4571631B2/ja not_active Expired - Fee Related
- 2004-07-01 DE DE602004012268T patent/DE602004012268T2/de not_active Expired - Lifetime
- 2004-07-01 DK DK04740542T patent/DK1644351T3/da active
- 2004-07-01 NZ NZ544454A patent/NZ544454A/en unknown
- 2004-07-02 MY MYPI20042649A patent/MY142085A/en unknown
-
2005
- 2005-12-26 IL IL172821A patent/IL172821A/en not_active IP Right Cessation
- 2005-12-29 CO CO05131363A patent/CO5660258A2/es not_active Application Discontinuation
-
2006
- 2006-01-03 ZA ZA200600026A patent/ZA200600026B/en unknown
- 2006-01-06 NO NO20060112A patent/NO20060112L/no not_active Application Discontinuation
-
2008
- 2008-04-15 HR HR20080173T patent/HRP20080173T3/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MEP22008A (en) | Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics | |
HRP20080173T3 (en) | IMIDAZOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF mGluR5 RECEPTOR MEDIATED DISORDERS | |
HRP20070529T3 (en) | Imidazole derivatives as glutmate receptor antagonists | |
MEP12708A (en) | Derivatives of n-[phenyl (alkylpiperidine-2-yl) methyl]benzamide, preparation method thereof and application of same in therapeutics | |
RS50378B (sr) | N-heterociklični derivati kao nos inhibitori | |
MXPA04006322A (es) | Derivados de 6-fluorobiciclo[3.1.0]hexano. | |
MEP12608A (en) | Derivatives of n-[phenyl (pyrrolidine-2-yl) methyl]benzamide and n-[(azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics | |
DK0862567T3 (da) | 5-azabicyclo[3.1.0]hexylalkyl-2-piperidoner og-glutarimider som neurokininreceptorantagonister | |
SG169900A1 (en) | 4 - (3,4 - disubstituted phenyl) - pyrrolidin-2-one compounds as phosphodiesterase 4 inhibitors | |
WO2003106428A8 (fr) | Derives d'arylsulfonamides et leur utilisation en tant que antagonistes au recepteur b1 de la bradykinine | |
RS50932B (sr) | N-oksidi kao prolekovi 4-fenil-piridinskih derivata koji su antagonisti nk1 receptora | |
NO20101069L (no) | Anvendelse av visse NMDA-affinitetsantagonister som antidepressiva | |
HRP20090162T1 (en) | Quinolinone-carboxamide compounds as 5-ht4 receptor agonists | |
HRP20070430T3 (en) | (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity | |
NZ533310A (en) | Benzimidazoles useful as protein kinase inhibitors | |
NO20060206L (no) | Nye azetidinforbindelser | |
EA200201259A1 (ru) | Производные бензимидазола, их получение и терапевтическое применение | |
WO2002038565A3 (de) | 7-(r)-amino-triazolopyrimidine, deren herstellung und verwendung zur bekämpfung von pflanzenpathogenen pilzen | |
HRP20070286T3 (en) | Substituted diketopiperazines and their use as oxytocyn antagonists | |
WO2003031442A1 (fr) | Composes heterocycliques, derives oxazole, procede permettant de les presenter et leur utilisation | |
ATE295836T1 (de) | Carboxamide und ihre verwendung als inhibitoren des mikrosomalen triglycerid-transfer-proteins und der apolipoprotein b (apo b) sekretion | |
HRP20080363T3 (en) | Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as mglu5 receptor antagonists | |
YU46787B (sh) | Derivati heteroaril 3-okso-propan-nitrila i postupak za njihovo dobijanje | |
DK0510003T3 (da) | Piperidin-og pyrrolidinderivater | |
HRP20040230B1 (en) | Muscarinic agonists |